UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 20, 2022
Accession Number:
0001104659-22-108844
Submission Type:
POS AM
CIK:
0001815903
Company Name:
Petros Pharmaceuticals, Inc.
File Number:
333-262038